Triple Negative Breast Neoplasms Clinical Trials
2 recruiting trials for Triple Negative Breast Neoplasms. Eligibility criteria explained in plain English.
2
Total Trials
2
Recruiting Now
0
Phase 3 Trials
2
Sponsors
Recruiting Trials
RECRUITINGPhase 1 / Phase 2NCT06380816
A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer
This clinical trial is looking at UCB4594. This is the first time the drug is being tested in humans. UCB4594 is a type of drug called a monoclonal antibody. It has been designed...
Sponsor: Cancer Research UKEnrolling: 1672 locations
RECRUITINGPhase 2NCT06365788
Bicalutamide and Abemaciclib in Inoperable or Metastatic Androgen Receptor-positive Triple-negative Breast Cancer
This study has as goal to evaluate the use of abemaciclib and bicalutamide in androgen receptor positive metastatic triple negative breast cancer.
Sponsor: Universitaire Ziekenhuizen KU LeuvenEnrolling: 536 locations